Medical Writing Intern, Market Access (PharmD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Precision Medicine Group ยท 2 months ago

Medical Writing Intern, Market Access (PharmD)

Precision Medicine Group is offering an immersive internship program for PharmD graduates. As a Medical Writing Intern, you will work with the Market Access team to develop content for pharmaceutical marketing materials and gain exposure to medical writing principles.

BiotechnologyHealth Care

Responsibilities

Work closely with the Market Access team to gain exposure to the principles of medical writing
Develop content for a range of deliverables targeting access decision makers
Build essential skills in evaluating scientific literature, coordinating references, and verifying the accuracy of cited information used in pharmaceutical marketing materials and medical, legal, and regulatory submissions

Qualification

PharmDMedical writingScientific literature evaluationMicrosoft OfficeAdobe AcrobatAMA style guideWritten communicationVerbal communicationProject management

Required

PharmD candidates expected to graduate by June 2026
Impeccable written and verbal communications skills
Expertise in gathering, evaluating, and summarizing scientific literature
Proficiency of Microsoft Office (PowerPoint, Word, Excel) and Adobe Acrobat

Preferred

Working knowledge of AMA style guide
Prior experience in areas such as Medical and Drug Information
Prior experience in areas such as Medical Affairs
Prior experience in areas such as Regulatory Affairs
Prior experience in areas such as New Product Commercialization
Prior experience in areas such as Promotional Agencies
Working knowledge of managed markets, healthcare systems, and healthcare delivery
Involvement in professional organizations such as Academy of Managed Care Pharmacy (AMCP) and Industry Pharmacists Organization (IPhO)

Company

Precision Medicine Group

company-logo
We founded Precision Medicine Group in 2012 because we believed there was a transformational opportunity to improve the process of bringing new drugs to market.

Funding

Current Stage
Late Stage

Leadership Team

leader-logo
Mark Clein
Co-Founder & Chief Executive Officer
linkedin
leader-logo
Matt DeZee
Chief Financial Officer
linkedin
Company data provided by crunchbase